Please wait while we load the requested 10-Q report or click the link below:
USANA Health Sciences Reports Third Quarter Financial Results
- Record third quarter net sales of $261.8 million, an increase of 3.0% year-over-year
- Number of active Customers1 at quarter end increased 2.4% to 563,000
- Third quarter EPS of $0.97, or $1.02 excluding incremental expense related to China and the Company’s previously disclosed internal investigation
- Company updates 2017 outlook
SALT LAKE CITY--(BUSINESS WIRE)--October 24, 2017--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended September 30, 2017.
For the third quarter of 2017, net sales were $261.8 million compared with $254.2 million in the prior-year period, or a 3.0% increase year-over-year. There was no meaningful year-over-year impact from changes in currency exchange rates on quarterly net sales. The Company’s total number of active Customers increased by 2.4% year-over-year to 563,000.
The following information was filed by Usana Health Sciences Inc (USNA) on Tuesday, October 24, 2017 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one quarter to another to evaluate Usana Health Sciences Inc's financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were
removed , and by Usana Health Sciences Inc.